Page 16 - 南京医科大学自然版
P. 16

第44卷第6期
               ·752 ·                            南 京    医 科 大 学 学         报                        2024年6月


                   2016,34(1):57-58                                  Dis,2016,22(11):1985-1987
             [14]中华人民共和国国家卫生健康委员会. 关于印发鼠疫                       [22]曹卫友,王      欣,刘   硕,等. 发热伴血小板减少综合征
                   等传染病诊疗方案(2023 年版)的通知——发热伴血                        患者血清内抗体 IgG 中和活性及其影响因素分析[J].
                   小 板 减 少 综 合 征 诊 疗 方 案(2023 年 版 )[EB/OL].          病毒学报,2022,38(1):123-128
                  (2023- 12- 28)[2024- 01- 03]. http://www.nhc.gov.cn/  [23] GUO X,ZHANG L,ZHANG W,et al. Human antibody
                   ylyjs/pqt/202312/75cfff021a484d0c9c200f85f2bf746b. ht⁃  neutralizes severe fever with thrombocytopenia syndrome
                   ml                                                virus,an emerging hemorrhagic Fever virus[J]. Clin
             [15]马静阁,刘       宁,刘紫嫣,等. 我国致病性蜱媒病毒流行                    Vaccine Immunol,2013,20(9):1426-1432
                   现状[J]. 中国血吸虫病防治杂志,2023,35(4):325-330         [24]KIM K H,KIM J,KO M,et al. An anti⁃Gn glycoprotein
             [16] TANG X,WU W,WANG H,et al. Human ⁃ to ⁃ human       antibody from a convalescent patient potently inhibits the
                   transmission of severe fever with thrombocytopenia syn⁃  infection of severe fever with thrombocytopenia syndrome
                   drome bunyavirus through contact with infectious blood[J].  virus[J]. PLoS Pathog,2019,15(2):e1007375
                   J Infect Dis,2013,207(5):736-739             [25]MOMING A,SHI S,SHEN S,et al. Fine mapping epitope
             [17]JUNG I Y,CHOI W,KIM J,et al. Nosocomial person⁃to⁃  on glycoprotein⁃Gn from severe fever with thrombocytope⁃
                   person transmission of severe fever with thrombocytope⁃  nia syndrome virus[J]. PLoS One,2021,16(3):e0248005
                   nia syndrome[J]. Clin Microbiol Infect,2019,25(5):  [26]LEE K,CHOI M J,CHO M H,et al. Antibody production
                   633.e1-633.e4                                     and characterization of the nucleoprotein of sever fever
             [18]FANG X,HU J,PENG Z,et al. Epidemiological and clini⁃  with thrombocytopenia syndrome virus(SFTSV)for effec⁃
                   cal characteristics of severe fever with thrombocytopenia  tive diagnosis of SFTSV[J]. Virol J,2023,20(1):206
                   syndrome bunyavirus human⁃to⁃human transmission[J].  [27]李清群,杨卓轩,石  彬. B 细胞受体(BCR)抗原特异
                   PLoS Negl Trop Dis,2021,15(4):e0009037            性的研究进展[J]. 细胞与分子免疫学杂志,2023,39
             [19]杨    鑫,武永祥,冷      昱,等. 两起发热伴血小板减少综                 (7):663-670
                   合征聚集性疫情流行病学及病原学分析[J]. 遗传,                    [28] SUZUKI T,SATO Y,SANO K,et al. Severe fever with
                   2023,45(11):1062-1073                             thrombocytopenia syndrome virus targets B cells in lethal
             [20]WEN Y,FANG Y,CAO F,et al. A person⁃to⁃person trans⁃  human infections[J]. J Clin Invest,2020,130(2):799-
                   mission cluster of severe fever with thrombocytopenia syn⁃  812
                   drome characterized by mixed viral infections with famil⁃  [29]PARK A,PARK S J,JUNG K L,et al. Molecular signa⁃
                   ial and nosocomial clustering[J]. Heliyon,2024,10(2):  tures of inflammatory profile and B⁃cell function in patients
                   e24502                                            with severe fever with thrombocytopenia syndrome[J].
             [21]HUANG Y T,ZHAO L,WEN H L,et al. Neutralizing anti⁃  mBio,2021,12(1):e02583-e025820
                   bodies to severe fever with thrombocytopenia syndrome                  [收稿日期] 2024-02-27
                   virus 4 years after hospitalization,China[J]. Emerg Infect                 (本文编辑:蒋       莉)
   11   12   13   14   15   16   17   18   19   20   21